DNTH212 is a bifunctional fusion protein targeting plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while simultaneously inhibiting BAFF/APRIL to suppress B cell ...

With consensus analyst price targets ranging from $12.00 to $52.00, VSAT is outpacing nearly every peer and capturing the attention of both AI-powered strategies and Wall Street’s top minds (as well ...

DNTH212 is a bifunctional fusion protein targeting plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while ...